Cognyte shares surge 9% on second quarter earnings beat

Cognyte reported Q2 adjusted EPS of $0.15, beating the $0.11 consensus by $0.04, while revenue rose 12% year over year to $109.2 million, modestly above the $108.51 million estimate. Software revenue grew 21% to $100.8 million and adjusted EBITDA increased 36% to $14.9 million, supporting an 8.92% jump in shares. The company reiterated FY2027 midpoint guidance for $448 million of revenue, approximately 12% growth, $68 million of adjusted EBITDA, and non-GAAP EPS of $0.47.

Analysis

The key investable signal is operating leverage: software growth is converting into profit faster than the top line, which can support a re-rating if management proves the model is durable through the remaining fiscal year. However, the modest beat against maintained full-year targets implies the upside is principally a confidence-in-execution trade, not yet an earnings-revision cycle. For a small-cap security/intelligence software name, that distinction matters: a post-results gap can fade quickly without a guide raise, material backlog disclosure, or evidence that recurring mix is expanding faster than services and license volatility.

The competitive read-through is selectively favorable for Palantir (PLTR), CACI (CACI), Leidos (LDOS), and Booz Allen (BAH): sovereign AI and investigative analytics spending remains a resilient budget pocket relative to discretionary enterprise software. CGNT's product-led momentum could also pressure smaller government-security software vendors competing for law-enforcement and intelligence procurement, but its scale limits broad sector extrapolation. The more consequential second-order issue is procurement duration: sovereign customers can create sticky renewals and high switching costs, yet also make quarterly revenue timing lumpy and expose the company to delayed contract awards.

Near term, the stock is vulnerable to profit-taking after the gap because the valuation impact depends on whether EBITDA guidance proves conservative. Over 1-3 months, contract wins, backlog/RPO growth, and a higher recurring-revenue mix are the needed catalysts; absent those, the market may treat the quarter as fully reflected. Over 6-18 months, sustained margin expansion could justify a higher multiple, but this is falsified by recurring revenue decelerating below the low-teens, FY EBITDA guidance remaining unchanged after another beat, or a material increase in sales-and-marketing intensity to sustain growth.

Key Decisions for Investors

• Do not chase CGNT in the immediate post-earnings move. Establish a starter long only on a 5-10% pullback or after independently verifying backlog/RPO and the implied second-half revenue cadence; target a 15-25% upside over 3-6 months if management raises FY EBITDA or revenue guidance, with a stop if recurring growth falls below 12%.
• For investors seeking the theme with greater liquidity, maintain a relative-value basket long PLTR and CACI versus a broad software ETF (IGV) for 3-6 months. The thesis is that sovereign/security AI budgets are less exposed to commercial IT spending; reduce if US federal procurement delays broaden or PLTR's government growth decelerates materially.
• Use the next earnings report as the decision catalyst: add to CGNT only if recurring mix rises and the company converts the current operating leverage into a full-year guide increase. If results again exceed estimates while guidance stays flat, treat that as evidence of limited visibility rather than an acceleration signal and avoid increasing exposure.
• Monitor customer concentration, deferred revenue/RPO, cash conversion, and stock-based compensation before underwriting a multiple expansion. Missing disclosure on these metrics is a watch item, not a basis for an options trade in a likely less-liquid small-cap name.